Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673292 · ClinicalTrials.gov registry record · NA
Community Collaboration to Combat COVID-19 (C-FORWARD)
A NA study of Coronavirus Infection, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 831
- Enrollment target
- 1
- Study location
NCT04673292 is a NA study of Coronavirus Infection that has completed, run by Johns Hopkins University. The registered enrollment target is 831 participants, above the 194-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (328% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04673292, a NA study of Coronavirus Infection, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 831 participants
- Enrollment target
- 1
- Study location
Study Summary
This is randomized trial where households will be randomized to identify the optimal SARS-CoV-2 (COVID-19) testing modality in a population-representative sample of households in Baltimore City, Maryland. 1,386 households in Baltimore City will be randomized 1:1:1 to one of three testing modalities: 1) fixed-site standard of care testing; 2) community-based mobile van testing; or 3) self-collected home, based testing.
Conditions Studied
Interventions
- BEHAVIORAL Fixed site standard of care testing
- BEHAVIORAL Community-based, mobile van testing
- BEHAVIORAL Self-collected, home-based testing
Study Locations (1)
Maryland
- 2212 McElderry Street - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 831 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2023-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04673292
The ClinicalTrials.gov registry entry for NCT04673292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 831 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 194-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (328% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronavirus Infection appearing as the primary indexed condition, and to 3 interventions - of which Fixed site standard of care testing is the first listed.
NCT04673292 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04673292 about?
NCT04673292 is a clinical study titled "Community Collaboration to Combat COVID-19 (C-FORWARD)". This is randomized trial where households will be randomized to identify the optimal SARS-CoV-2 (COVID-19) testing modality in a population-representative sample of households in Baltimore City, Maryland. 1,386 households in Baltimore City will be randomized 1:1:1 to one of three testing modalities:...
What is the current status of trial NCT04673292?
This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2021-02-08. Estimated completion is 2023-06-09.
What conditions does trial NCT04673292 study?
This clinical trial studies the following conditions: Coronavirus Infection.
What interventions are being tested in trial NCT04673292?
The interventions under investigation include: Fixed site standard of care testing (BEHAVIORAL), Community-based, mobile van testing (BEHAVIORAL), Self-collected, home-based testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673292?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04673292 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment
COMPLETED · NA
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
-
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
RECRUITING
-
Post COVID-19 Biorepository
RECRUITING
-
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
COMPLETED
-
COVID-19 and Lactating Mothers
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.